Skip to content

Ibogaine: all studies

Page 22 of 62: studies 211 to 220 of 613, newest first. Back to the ibogaine overview

Research

The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation

Molecules January 29, 2015 Xaver Koenig, Karlheinz Hilber 123 citations

The plant indole alkaloid ibogaine has shown promising anti-addictive properties in animal studies. Ibogaine is also anti-addictive in humans as the drug alleviates drug craving and impedes relapse of drug use. Although not licensed as therapeutic drug and despite safety concerns, ibogaine is currently used as an anti-addiction medication in alternative medicine in dozens of clinics worldwide....

DOI: 10.3390/molecules20022208 (opens in new tab) Addiction Drug Pharmacology Indole alkaloid +1

Treating drug dependence with the aid of ibogaine: a retrospective study.

Journal of Psychopharmacology November 1, 2014 Eduardo Ekman Schenberg, Maria Angélica de Castro Comis, Bruno Rasmussen Chaves et al. 110 citations

Ibogaine is an alkaloid purported to be an effective drug dependence treatment. However, its efficacy has been hard to evaluate, partly because it is illegal in some countries. In such places, treatments are conducted in underground settings where fatalities have occurred. In Brazil ibogaine is unregulated and a combined approach of psychotherapy and ibogaine is being practiced to treat...

Iboga-Type Alkaloids from Ervatamia officinalis.

Journal of Natural Products August 22, 2014 Ben-Qin Tang, Wen-Jing Wang, Xiao-Jun Huang et al.

Seven new iboga-type alkaloids, ervaoffines A-D (1-4), (7S)-3-oxoibogaine hydroxyindolenine (5), ibogaine-5,6-dione (6), and 19-epi-5-oxovoacristine (7), and 10 known alkaloids were isolated from Ervatamia officinalis. The absolute configurations of 1-7 were determined through X-ray diffraction and electronic circular dichroism (ECD) analyses. Ervaoffines A and B represent the first iboga-type...

Anti-addiction drug ibogaine inhibits hERG channels: a cardiac arrhythmia risk.

Addiction Biology March 1, 2014 Xaver Koenig, Michael Kovar, Stefan Boehm et al. 50 citations

Ibogaine, an alkaloid derived from the African shrub Tabernanthe iboga, has shown promising anti-addictive properties in animals. Anecdotal evidence suggests that ibogaine is also anti-addictive in humans. Thus, it alleviates drug craving and impedes relapse of drug use. Although not licensed as therapeutic drug, and despite evidence that ibogaine may disturb the rhythm of the heart, this...

DOI: 10.1111/j.1369-1600.2012.00447.x (opens in new tab) Full text (opens in new tab) Anti-addiction drug Qt interval prolongation Herg potassium channels Indole alkaloid +5

Mechanism of hERG channel block by the psychoactive indole alkaloid ibogaine.

Journal of Pharmacology and Experimental Therapeutics February 1, 2014 Patrick Thurner, Anna Stary-Weinzinger, Hend Gafar et al. 41 citations

Ibogaine is a psychoactive indole alkaloid. Its use as an antiaddictive agent has been accompanied by QT prolongation and cardiac arrhythmias, which are most likely caused by human ether a go-go-related gene (hERG) potassium channel inhibition. Therefore, we studied in detail the interaction of ibogaine with hERG channels heterologously expressed in mammalian kidney tsA-201 cells. Currents...

Psychedelics as medicines for substance abuse rehabilitation: evaluating treatments with LSD, Peyote, Ibogaine and Ayahuasca.

Current Drug Abuse Reviews 2014 Michael Winkelman 128 citations

Substances known as psychedelics, hallucinogens and entheogens have been employed in ethnomedical traditions for thousands of years, but after promising uses in the 1950's and 1960's they were largely prohibited in medical treatment and human research starting in the 1970's as part of the fallout from the war on drugs. Nonetheless, there are a number of studies which suggest that these...

DOI: 10.2174/1874473708666150107120011 (opens in new tab) Full text (opens in new tab) Psychedelic addiction treatment Psychedelic therapeutic mechanisms Psychedelic drug safety

Anti-addiction drug ibogaine inhibits voltage-gated ionic currents: a study to assess the drug's cardiac ion channel profile.

Toxicology and Applied Pharmacology December 1, 2013 Xaver Koenig, Michael Kovar, Lena Rubi et al. 46 citations

The plant alkaloid ibogaine has promising anti-addictive properties. Albeit not licensed as a therapeutic drug, and despite hints that ibogaine may perturb the heart rhythm, this alkaloid is used to treat drug addicts. We have recently reported that ibogaine inhibits human ERG (hERG) potassium channels at concentrations similar to the drugs affinity for several of its known brain targets....

DOI: 10.1016/j.taap.2013.05.012 (opens in new tab) Full text (opens in new tab) 18-mc 18-methoxycoronaridine Ap Anti-addiction drug +8

Ibogaine related sudden death: a case report.

Journal of Forensic and Legal Medicine October 1, 2013 Stavroula A Papadodima, Artemis Dona, Christos I Evaggelakos et al. 21 citations

Ibogaine is a naturally occurring alkaloid derived from the roots of the rain forest shrub Tabernanthe iboga. Deaths have occurred temporarily related to the use of ibogaine. However, although not licensed as therapeutic drug, and despite evidence that ibogaine may disturb the rhythm of the heart, this alkaloid is currently used as an anti-addiction drug in alternative medicine for...

DOI: 10.1016/j.jflm.2013.06.032 (opens in new tab) Full text (opens in new tab) Cardiac death Ibogaine risks: ibogaine Anti-addiction compound Alternative medicine +13

Ibogaine in the treatment of substance dependence.

Current Drug Abuse Reviews March 1, 2013 Thomas Kingsley Brown 105 citations

Ibogaine is a psychoactive alkaloid derived from Tabernanthe iboga, a plant used in initiatory rituals in West Central Africa. Largely because of ibogaine's status as a Schedule I substance in the U.S., the development of ibogaine's use in the treatment of drug addiction took place outside conventional clinical and medical settings. This article reviews the history of ibogaine's use in the...

DOI: 10.2174/15672050113109990001 (opens in new tab) Full text (opens in new tab) Addiction treatment Substance dependence treatment Drug addiction therapy Anti-addictive treatment +19

Unique and potent effects of acute ibogaine on zebrafish: the developing utility of novel aquatic models for hallucinogenic drug research.

Behavioural Brain Research 2013 Jonathan Cachat, Evan J. Kyzar, Christopher Collins et al. 112 citations

An indole alkaloid, ibogaine is the principal psychoactive component of the iboga plant, used by indigenous peoples in West Africa for centuries. Modulating multiple neurotransmitter systems, the drug is a potent hallucinogen in humans, although its psychotropic effects remain poorly understood. Expanding the range of model species is an important strategy for translational neuroscience...

DOI: 10.1016/j.bbr.2012.08.041 (opens in new tab) Full text (opens in new tab) Zebrafish model Zebrafish research Animal model Aquatic model +31